Arecor Therapeutics PLC AREC.L
GBX77.50 GBX1.00 (1.31%) 1D
Last Updated: Sep 07, 12:00 AM·LSE
Pricing for GB stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Arecor Therapeutics PLC Stock Halal?
Shariah Compliance Analysis of AREC.L Stock
United Kingdom Health Care Nano Cap Yes. As of September 2026, Arecor Therapeutics PLC (AREC.L) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Arecor Therapeutics PLC passes Musaffa's business and financial screening criteria.
Arecor Therapeutics Plc is a biopharmaceutical company that targets improving patient care by bringing medicines to market through the enhancement of existing therapeutic products. The company is headquartered in Saffron Walden, Essex. The company went IPO on 2021-06-03. The Company, by applying its technology platform, Arestat, is developing an internal portfolio of products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver therapeutic products. Its in-house development programs include AT278, Oral GLP-1 and AT247. AT278 is its ultra-concentrated, ultra-rapid acting insulin candidate. AT278 is designed to accelerate the absorption of insulin post injection even at very high concentrations (500U/mL). AT247 is designed to accelerate the absorption of insulin post injection. The company is focused on the development of an oral GLP-1 receptor agonist (semaglutide). The company has partnered with TRx Biosciences, combining its Arestat technology and TRx Biosciences' lipid technology, Lipicore, to target improved bioavailability of an oral GLP-1 receptor agonist. Its partnered programs include AT220, AT292 and AT351.
AREC.L Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Arecor Therapeutics PLC is classified as halal.
HALAL
Report Source: undefined Quarter Report
Arecor Therapeutics PLC (AREC.L) Chart
Financial Metrics & Statements of Arecor Therapeutics PLC (AREC.L)
FAQ's for Arecor Therapeutics PLC (AREC.L)
- As of September 2026, Arecor Therapeutics PLC AREC.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Arecor Therapeutics PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in Arecor Therapeutics PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Arecor Therapeutics PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Arecor Therapeutics PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Arecor Therapeutics PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Arecor Therapeutics PLC (AREC.L)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
